The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical presentation, natural history and therapeutic approach in patients with solitary fibrous tumor: A retrospective analysis.
 
Patrick Schoffski
Consulting or Advisory Role - Adaptimmune (Inst); Blueprint Medicines (Inst); Deciphera (Inst); Eisai (Inst); Ellipses Pharma (Inst); Genmab (Inst); Intellisphere (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Plexxikon (Inst); SERVIER (Inst); Transgene (Inst)
Research Funding - Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); CoBioRes NV (Inst); Eisai (Inst); Exelixis (Inst); G1 Therapeutics (Inst); Lilly (Inst); Novartis (Inst); PharmaMar (Inst); Plexxikon (Inst)
 
Iris Timmermans
No Relationships to Disclose
 
Daphne Hompes
No Relationships to Disclose
 
Marguerite Stas
Consulting or Advisory Role - B. Braun (Inst); Bristol-Myers Squibb (Inst); Perouse Medical (Inst)
Research Funding - Perouse Medical (Inst)
 
Veerle Boecxstaens
No Relationships to Disclose
 
Paul De Leyn
No Relationships to Disclose
 
Willy Coosemans
No Relationships to Disclose
 
Dirk Van Raemdonck
No Relationships to Disclose
 
Esther Hauben
No Relationships to Disclose
 
Raf Sciot
No Relationships to Disclose
 
Paul M. Clement
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); LEO Pharma (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Vifor Pharma (Inst)
Research Funding - AstraZeneca (Inst)
 
Oliver Edgar Bechter
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Pierre Fabre (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Benoit Beuselinck
Consulting or Advisory Role - Bristol-Myers Squibb (Inst)
Speakers' Bureau - Ipsen; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Feng Jung Sherida Harriette Woei-A-Jin
Consulting or Advisory Role - Takeda (Inst)
Travel, Accommodations, Expenses - Astellas Medivation
 
Herlinde Dumez
Travel, Accommodations, Expenses - Astellas Medivation; AstraZeneca; Bayer; Ipsen; MSD; Novartis; Pfizer; Roche; Sanofi
 
Tim Wessels
Speakers' Bureau - Vifor Pharma
Travel, Accommodations, Expenses - Ipsen; Pfizer